Association of Soluble Suppression of Tumorigenicity with No-Reflow Phenomenon and Long-Term Prognosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome after Percutaneous Coronary Intervention

Aims: Soluble suppression of tumorigenicity 2 (sST2) was validated to independently predict prognosis for heart failure (HF) and ST-segment elevation myocardial infarction (STEMI). In this study, we aimed to evaluate the relation between sST2 and coronary artery stenosis, and no-reflow phenomenon an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qinyao, Hu, Meirong, Ma, Shumei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629709/
https://www.ncbi.nlm.nih.gov/pubmed/33551392
http://dx.doi.org/10.5551/jat.59832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629709/
https://www.ncbi.nlm.nih.gov/pubmed/33551392
http://dx.doi.org/10.5551/jat.59832

Ejemplares similares